United Kingdom Children's Cancer Study Group (UKCCSG) radiotherapy and brain tumour groups: Medulloblastoma/PNET and craniospinal radiotherapy (CSRT): Report of a workshop held in Leeds, 30 June 1999

Clinical Oncology

Volumn 13, Issue 1, 2001, Pages 58-64

  Taylor, R E ^a  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Craniospinal radiotherapy; Medulloblastoma; PNET; Radiotherapy planning; Radiotherapy quality assurance

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; HYDROXYUREA; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ACCURACY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CHILD; CHILDHOOD CANCER; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; METASTASIS; NEUROECTODERM TUMOR; NORTH AMERICA; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; SURVIVAL; TECHNIQUE; TREATMENT PLANNING; UNITED KINGDOM; WORKSHOP;

EID: 0035117330     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9217     Document Type: Article

References (31)

1. Rorke LB. The cerebellar medulloblastoma in its relationship to primitive neuroectodermal tumors [presidential address]. J Neuropathol Exp Neurol 1983;42:1-15.
2. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68.
3. Stiller CA. Aetiology and epidemiology. In: Pinkerton CR, Plowman PN, editors. Paediatric oncology: clinical practice and controversies. 2nd ed. London: Chapman and Hall, 1997:3-26.
4. Deutsch M. Medulloblastoma: staging and treatment outcome. Int J Radiat Oncol Biol Phys 1988;14:1103-7.
5. Bloom HJG, Glees J, Bell J. The treatment and long-term prognosis of medulloblastoma in children. Am J Roentgenol 1969;105:43-62.
6. Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995;2:166-78.
7. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis, stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized Phase III study. J Clin Oncol 1999;17:832-45.
8. Kortmann R-D, Kuhl J, Timmermann B, et al. Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000;46:269-79.
9. Carrie C, Alapetite C, Mere P, et al. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol 1992;24:77-81.
10. Carrie C, Hoffstetter S, Gomez F, et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999;45:435-9.
11. Stiller CA, Bunch KJ. Trends in survival for childhood cancer in Britain diagnosed 1971-85. Br J Cancer 1990;62:806-15.
12. Evans AE, Jenkins RD, Sposto R, et al. The treatment of medulloblastoma: results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 1990;72:572-82.
13. Tait DM, Thornton-Jones H, Bloom HJ, et al. Adjuvant chemotherapy for medulloblastoma: the first multicentre controlled trial of the International Society of Paedistric Oncology (SIOP). Eur J Cancer 1990;26:464-9.
14. Deutsch M, Thomas PR, Krischer J, et al. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3600 cGy/20) with reduced neuraxis irradiation (2340 cGy/13) in patients with low-stage medulloblastoma. Pediatr Neurosurg 1996;24:167-77.
15. Hirsch JF, Renier D, Czernichow P, et al. Medulloblastoma in childhood: survival and functional results. Acta Neurochir 1979;48:1-15.
16. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999;45:137-45.
17. Mulhern RK, Kepner JL, Thomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1723-8.
18. Miralbell R, Lomex A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/ primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys 1997;38:477-84.
19. Kun LE, Mulhern RK, Crisco JJ. Quality of life in children treated for brain tumors: intellectual, emotional and academic function. J Neurosurg 1983;58:1-6.
20. Jannoun I, Bloom HJG. Long-term psychological effects in children treated for intracranial tumors. Int J Radiat Oncol Biol Phys 1990;18:747-53.
21. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group study. J Clin Oncol 1999;17:2127-36.
22. Hughes EN, Shillito J, Sallan SE, et al. Medulloblastoma at the Joint Centre for Radiation therapy between 1968 and 1984. Cancer 1988;61:1992-8.
23. Jenkin D, Goddard K, Armstrong D, et al. Posterior medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990;19:265-74.
24. Allen JC, Donahue B, DaRosso R, et al. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neurectodermal tumors. Int J Radiat Oncol Biol Phys 1996;36:1155-61.
25. Prados MD, Edwards MS, Chang SM, et al. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Int J Radiat Oncol Biol Phys 1999;43:279-85.
26. Van Dyk J, Jenkin RTD, Leung PMK, et al. Medulloblastoma: treatment technique and radiation dosimetry. Int J Radiat Oncol Biol Phys 1977;2:993-1005.
27. Maguire A, Craft A, Evans R. The long-term effects of treatment on the dental condition of children surviving malignant disease. Cancer 1987;60:2570-5.
28. Halperin EC. Concerning the inferior portion of the spinal radiotherapy field for malignancies that disseminate via the cerebrospinal fluid. Int J Radiat Oncol Biol Phys 1993;26:357-62.
29. Kiltie AE, Povall JM, Taylor RE. The need for the moving junction in craniospinal irradiation. Br J Radiol 2000;73:650-4.
30. Fukunaga-Johnson N, Sandler HM, Marsh R, et al. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma. Int J Radiat Oncol Biol Phys 1998;41:77-82.
31. Fukunaga-Johnson N, Lee JH, Sandler HM, et al. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa? Int J Radiat Oncol Biol Phys 1998;42:143-6.